Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction
OBJECTIVE—To test whether equivalent energy expenditure by moderate-intensity (eg, walking) and vigorous-intensity exercise (eg, running) provides equivalent health benefits. APPROACH AND RESULTS—We used the National Runners’ (n=33 060) and Walkers’ (n=15 945) Health Study cohorts to examine the eff...
Gespeichert in:
| Veröffentlicht in: | Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2013-05, Vol.33 (5), p.1085-1091 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1091 |
|---|---|
| container_issue | 5 |
| container_start_page | 1085 |
| container_title | Arteriosclerosis, thrombosis, and vascular biology |
| container_volume | 33 |
| creator | Williams, Paul T Thompson, Paul D |
| description | OBJECTIVE—To test whether equivalent energy expenditure by moderate-intensity (eg, walking) and vigorous-intensity exercise (eg, running) provides equivalent health benefits.
APPROACH AND RESULTS—We used the National Runners’ (n=33 060) and Walkers’ (n=15 945) Health Study cohorts to examine the effect of differences in exercise mode and thereby exercise intensity on coronary heart disease (CHD) risk factors. Baseline expenditure (metabolic equivant hours per day [METh/d]) was compared with self-reported, physician-diagnosed incident hypertension, hypercholesterolemia, diabetes mellitus, and CHD during 6.2 years follow-up. Running significantly decreased the risks for incident hypertension by 4.2% (P |
| doi_str_mv | 10.1161/ATVBAHA.112.300878 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1326730714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1326730714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4588-abad7460c394c23b822e157edeb8bafdac24ed2f83eafddb6a42a747b739e24e3</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMobk7_gBfSSy9WTU7SpLuc82PCRBCd4E1I21NXl7UzaZH9ezM2vQjJS97ncHgIOWf0ijHJrsev85vxdBwCXHFKU5UekD5LQMRCcnkY3lSN4kQK6JET778opQKAHpMe8CQZSUj75OPd2GVVf0ZzdL7z0UtX19tYNi6abtboWqx91dTDaLJoLPoWXWOHkamL6LYyGbbooye0tmq3cOWX0QsWXd4G5JQclcZ6PNvfA_J2f_c6mcaz54fHyXgW5yJJ09hkplBC0pyPRA48SwGQJQoLzNLMlIXJQWABZcoxpCKTRoBRQmWKjzB88QG53M1du-a7CyvqVeXzsJOpsem8Zhyk4lQxEaqwq-au8d5hqdeuWhm30YzqrVO9dxoC6J3TAF3s53fZCot_5E9iKIhd4aexwY9f2u4HnV6gse1Cb61zSZMYKOM0CTEOJ2C_DMmDcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1326730714</pqid></control><display><type>article</type><title>Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Williams, Paul T ; Thompson, Paul D</creator><creatorcontrib>Williams, Paul T ; Thompson, Paul D</creatorcontrib><description><![CDATA[OBJECTIVE—To test whether equivalent energy expenditure by moderate-intensity (eg, walking) and vigorous-intensity exercise (eg, running) provides equivalent health benefits.
APPROACH AND RESULTS—We used the National Runners’ (n=33 060) and Walkers’ (n=15 945) Health Study cohorts to examine the effect of differences in exercise mode and thereby exercise intensity on coronary heart disease (CHD) risk factors. Baseline expenditure (metabolic equivant hours per day [METh/d]) was compared with self-reported, physician-diagnosed incident hypertension, hypercholesterolemia, diabetes mellitus, and CHD during 6.2 years follow-up. Running significantly decreased the risks for incident hypertension by 4.2% (P<10), hypercholesterolemia by 4.3% (P<10), diabetes mellitus by 12.1% (P<10), and CHD by 4.5% per METh/d (P=0.05). The corresponding reductions for walking were 7.2% (P<10), 7.0% (P<10), 12.3% (P<10), and 9.3% (P=0.01). Relative to <1.8 METh/d, the risk reductions for 1.8 to 3.6, 3.6 to 5.4, 5.4 to 7.2, and ≥7.2 METh/d were as follows(1) 10.1%, 17.7%, 25.1%, and 34.9% from running and 14.0%, 23.8%, 21.8%, and 38.3% from walking for hypercholesterolemia; (2) 19.7%, 19.4%, 26.8%, and 39.8% from running and 14.7%, 19.1%, 23.6%, and 13.3% from walking for hypertension; and (3) 43.5%, 44.1%, 47.7%, and 68.2% from running, and 34.1%, 44.2% and 23.6% from walking for diabetes mellitus (walking >5.4 METh/d excluded for too few cases). The risk reductions were not significantly different for running than walking for diabetes mellitus (P=0.94), hypertension (P=0.06), or CHD (P=0.26), and only marginally greater for walking than running for hypercholesterolemia (P=0.04).
CONCLUSIONS—Equivalent energy expenditures by moderate (walking) and vigorous (running) exercise produced similar risk reductions for hypertension, hypercholesterolemia, diabetes mellitus, and possibly CHD.]]></description><identifier>ISSN: 1079-5642</identifier><identifier>EISSN: 1524-4636</identifier><identifier>DOI: 10.1161/ATVBAHA.112.300878</identifier><identifier>PMID: 23559628</identifier><language>eng</language><publisher>United States: American Heart Association, Inc</publisher><subject>Adult ; Aged ; Cholesterol - blood ; Cohort Studies ; Coronary Disease - prevention & control ; Diabetes Mellitus - prevention & control ; Energy Metabolism ; Female ; Humans ; Hypertension - prevention & control ; Male ; Middle Aged ; Prospective Studies ; Risk Reduction Behavior ; Running ; Walking</subject><ispartof>Arteriosclerosis, thrombosis, and vascular biology, 2013-05, Vol.33 (5), p.1085-1091</ispartof><rights>2013 American Heart Association, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4588-abad7460c394c23b822e157edeb8bafdac24ed2f83eafddb6a42a747b739e24e3</citedby><cites>FETCH-LOGICAL-c4588-abad7460c394c23b822e157edeb8bafdac24ed2f83eafddb6a42a747b739e24e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23559628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, Paul T</creatorcontrib><creatorcontrib>Thompson, Paul D</creatorcontrib><title>Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction</title><title>Arteriosclerosis, thrombosis, and vascular biology</title><addtitle>Arterioscler Thromb Vasc Biol</addtitle><description><![CDATA[OBJECTIVE—To test whether equivalent energy expenditure by moderate-intensity (eg, walking) and vigorous-intensity exercise (eg, running) provides equivalent health benefits.
APPROACH AND RESULTS—We used the National Runners’ (n=33 060) and Walkers’ (n=15 945) Health Study cohorts to examine the effect of differences in exercise mode and thereby exercise intensity on coronary heart disease (CHD) risk factors. Baseline expenditure (metabolic equivant hours per day [METh/d]) was compared with self-reported, physician-diagnosed incident hypertension, hypercholesterolemia, diabetes mellitus, and CHD during 6.2 years follow-up. Running significantly decreased the risks for incident hypertension by 4.2% (P<10), hypercholesterolemia by 4.3% (P<10), diabetes mellitus by 12.1% (P<10), and CHD by 4.5% per METh/d (P=0.05). The corresponding reductions for walking were 7.2% (P<10), 7.0% (P<10), 12.3% (P<10), and 9.3% (P=0.01). Relative to <1.8 METh/d, the risk reductions for 1.8 to 3.6, 3.6 to 5.4, 5.4 to 7.2, and ≥7.2 METh/d were as follows(1) 10.1%, 17.7%, 25.1%, and 34.9% from running and 14.0%, 23.8%, 21.8%, and 38.3% from walking for hypercholesterolemia; (2) 19.7%, 19.4%, 26.8%, and 39.8% from running and 14.7%, 19.1%, 23.6%, and 13.3% from walking for hypertension; and (3) 43.5%, 44.1%, 47.7%, and 68.2% from running, and 34.1%, 44.2% and 23.6% from walking for diabetes mellitus (walking >5.4 METh/d excluded for too few cases). The risk reductions were not significantly different for running than walking for diabetes mellitus (P=0.94), hypertension (P=0.06), or CHD (P=0.26), and only marginally greater for walking than running for hypercholesterolemia (P=0.04).
CONCLUSIONS—Equivalent energy expenditures by moderate (walking) and vigorous (running) exercise produced similar risk reductions for hypertension, hypercholesterolemia, diabetes mellitus, and possibly CHD.]]></description><subject>Adult</subject><subject>Aged</subject><subject>Cholesterol - blood</subject><subject>Cohort Studies</subject><subject>Coronary Disease - prevention & control</subject><subject>Diabetes Mellitus - prevention & control</subject><subject>Energy Metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - prevention & control</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Risk Reduction Behavior</subject><subject>Running</subject><subject>Walking</subject><issn>1079-5642</issn><issn>1524-4636</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhoMobk7_gBfSSy9WTU7SpLuc82PCRBCd4E1I21NXl7UzaZH9ezM2vQjJS97ncHgIOWf0ijHJrsev85vxdBwCXHFKU5UekD5LQMRCcnkY3lSN4kQK6JET778opQKAHpMe8CQZSUj75OPd2GVVf0ZzdL7z0UtX19tYNi6abtboWqx91dTDaLJoLPoWXWOHkamL6LYyGbbooye0tmq3cOWX0QsWXd4G5JQclcZ6PNvfA_J2f_c6mcaz54fHyXgW5yJJ09hkplBC0pyPRA48SwGQJQoLzNLMlIXJQWABZcoxpCKTRoBRQmWKjzB88QG53M1du-a7CyvqVeXzsJOpsem8Zhyk4lQxEaqwq-au8d5hqdeuWhm30YzqrVO9dxoC6J3TAF3s53fZCot_5E9iKIhd4aexwY9f2u4HnV6gse1Cb61zSZMYKOM0CTEOJ2C_DMmDcw</recordid><startdate>201305</startdate><enddate>201305</enddate><creator>Williams, Paul T</creator><creator>Thompson, Paul D</creator><general>American Heart Association, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201305</creationdate><title>Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction</title><author>Williams, Paul T ; Thompson, Paul D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4588-abad7460c394c23b822e157edeb8bafdac24ed2f83eafddb6a42a747b739e24e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cholesterol - blood</topic><topic>Cohort Studies</topic><topic>Coronary Disease - prevention & control</topic><topic>Diabetes Mellitus - prevention & control</topic><topic>Energy Metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - prevention & control</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Risk Reduction Behavior</topic><topic>Running</topic><topic>Walking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, Paul T</creatorcontrib><creatorcontrib>Thompson, Paul D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, Paul T</au><au>Thompson, Paul D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction</atitle><jtitle>Arteriosclerosis, thrombosis, and vascular biology</jtitle><addtitle>Arterioscler Thromb Vasc Biol</addtitle><date>2013-05</date><risdate>2013</risdate><volume>33</volume><issue>5</issue><spage>1085</spage><epage>1091</epage><pages>1085-1091</pages><issn>1079-5642</issn><eissn>1524-4636</eissn><abstract><![CDATA[OBJECTIVE—To test whether equivalent energy expenditure by moderate-intensity (eg, walking) and vigorous-intensity exercise (eg, running) provides equivalent health benefits.
APPROACH AND RESULTS—We used the National Runners’ (n=33 060) and Walkers’ (n=15 945) Health Study cohorts to examine the effect of differences in exercise mode and thereby exercise intensity on coronary heart disease (CHD) risk factors. Baseline expenditure (metabolic equivant hours per day [METh/d]) was compared with self-reported, physician-diagnosed incident hypertension, hypercholesterolemia, diabetes mellitus, and CHD during 6.2 years follow-up. Running significantly decreased the risks for incident hypertension by 4.2% (P<10), hypercholesterolemia by 4.3% (P<10), diabetes mellitus by 12.1% (P<10), and CHD by 4.5% per METh/d (P=0.05). The corresponding reductions for walking were 7.2% (P<10), 7.0% (P<10), 12.3% (P<10), and 9.3% (P=0.01). Relative to <1.8 METh/d, the risk reductions for 1.8 to 3.6, 3.6 to 5.4, 5.4 to 7.2, and ≥7.2 METh/d were as follows(1) 10.1%, 17.7%, 25.1%, and 34.9% from running and 14.0%, 23.8%, 21.8%, and 38.3% from walking for hypercholesterolemia; (2) 19.7%, 19.4%, 26.8%, and 39.8% from running and 14.7%, 19.1%, 23.6%, and 13.3% from walking for hypertension; and (3) 43.5%, 44.1%, 47.7%, and 68.2% from running, and 34.1%, 44.2% and 23.6% from walking for diabetes mellitus (walking >5.4 METh/d excluded for too few cases). The risk reductions were not significantly different for running than walking for diabetes mellitus (P=0.94), hypertension (P=0.06), or CHD (P=0.26), and only marginally greater for walking than running for hypercholesterolemia (P=0.04).
CONCLUSIONS—Equivalent energy expenditures by moderate (walking) and vigorous (running) exercise produced similar risk reductions for hypertension, hypercholesterolemia, diabetes mellitus, and possibly CHD.]]></abstract><cop>United States</cop><pub>American Heart Association, Inc</pub><pmid>23559628</pmid><doi>10.1161/ATVBAHA.112.300878</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1079-5642 |
| ispartof | Arteriosclerosis, thrombosis, and vascular biology, 2013-05, Vol.33 (5), p.1085-1091 |
| issn | 1079-5642 1524-4636 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1326730714 |
| source | MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection |
| subjects | Adult Aged Cholesterol - blood Cohort Studies Coronary Disease - prevention & control Diabetes Mellitus - prevention & control Energy Metabolism Female Humans Hypertension - prevention & control Male Middle Aged Prospective Studies Risk Reduction Behavior Running Walking |
| title | Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T03%3A49%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Walking%20Versus%20Running%20for%20Hypertension,%20Cholesterol,%20and%20Diabetes%20Mellitus%20Risk%20Reduction&rft.jtitle=Arteriosclerosis,%20thrombosis,%20and%20vascular%20biology&rft.au=Williams,%20Paul%20T&rft.date=2013-05&rft.volume=33&rft.issue=5&rft.spage=1085&rft.epage=1091&rft.pages=1085-1091&rft.issn=1079-5642&rft.eissn=1524-4636&rft_id=info:doi/10.1161/ATVBAHA.112.300878&rft_dat=%3Cproquest_cross%3E1326730714%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1326730714&rft_id=info:pmid/23559628&rfr_iscdi=true |